Go faster for the Patient, further with the Entrepreneur Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower and support entrepreneurs through our expert, integrated, multi-talented team. Jeito Capital is based in Paris with a presence in Europe and the United States. Follow us to get our latest news & job offers. Private equity and Biopharma

Type: Incubators & VCs

Smart Tools for Managing Medication HealthBeacon is a medical adherence technology company. We develop smart tools for managing medication.

Type: Startup Activities: healthtech Technologies: IoT

[Automatic translation follows] Facilitate access to care and health everywhere, for everyone! We are recruiting 🚀 libheros is the first e-health company that offers turnkey systems for mobilizing healthcare professionals throughout France for all types of care. Thanks to our network of +20,000 healthcare professionals (nurses, physiotherapists and midwives), our secure digital tools and our paramedical care coordinators, we are able to respond to various requests. libheros is aimed at several types of actors: -Individuals wishing to quickly find a healthcare professional for their home care. Hundreds of thousands of people are satisfied with our services every month -To health …

Type: Startup Activities: healthtech

Pionnier de la thérapie régénératrice cardiaque CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans. Heart Regeneration

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary …

Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Data Analytics A.I. - Machine Learning

Encouraging careful stewardship of clinical genetics, genomics and precision medicine. The Center for Genomic Interpretation (CGI) is an independent non-profit organization with the mission to save and improve lives through encouraging careful stewardship of clinical genetics, genomics, and precision medicine. Clinical Genetics, Human Genetics, Genetics, Variant Classification, Variant Interpretation, Mutation Analysis, Mutation Interpretation, Mutation Classification, Mutation, Service, Diagnostics, Precision Medicine, Genomics, Clinical Genomics, Consumer Genetics, Fraud, Waste, Abuse, and Health Insurance

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

BioPharma Asia is the premier publication for unbiased, cutting edge editorial written by the leading figures currently working in the global Pharma and BioPharma industry. With a circulation of 30,000 printed journals throughout Asia and distributed to a controlled circulation of Heads of Manufacturing, Senior Scientists and Middle-Senior Managers throughout Asia on a bi-monthly basis, BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures …

Type: Media